[Accepted Manuscript] In vitro susceptibility to closthioamide among clinical and reference strains of Neisseria gonorrhoeae.
V.F.
Miari
;
P.
Solanki
;
Y.
Hleba
;
R.A.
Stabler
;
J.T.
Heap
;
(2017)
[Accepted Manuscript] In vitro susceptibility to closthioamide among clinical and reference strains of Neisseria gonorrhoeae.
Antimicrobial agents and chemotherapy.
ISSN 0066-4804
DOI: 10.1128/AAC.00929-17
Neisseria gonorrhoeae is one of the leading antimicrobial resistance threats worldwide. This study determined the minimum inhibitory concentrations of closthioamide to be 0.008-0.5 mg/L for clinical N. gonorrhoeae strains and related species. Cross-resistance with existing antimicrobial resistance was not detected, indicating that closthioamide could be used to treat drug-resistant N. gonorrhoeae.
-
picture_as_pdf - In_vitro_susceptibility_GREEN AAM.pdf
-
subject - Accepted Version
-
- Available under Creative Commons: Attribution 3.0
Supplemental Material
Supplemental Material
Supplemental Material
Downloads